Transthyretin Tetramer Destabilization and Increased Mortality in the General Population [0.03%]
老年普通人群 thyroxine结合前白蛋白四级结构不稳定与死亡率增加相关性研究
Mette Christoffersen,Anders Møller Greve,Louise Stig Hornstrup et al.
Mette Christoffersen et al.
Importance: Transthyretin tetramer destabilization is the rate-limiting step in the development of transthyretin cardiac amyloidosis, an underrecognized contributor to mortality in older adults. ...
Aspirin for Secondary Prevention of Atherosclerosis-Evidence or Dogma? [0.03%]
动脉粥样硬化二级预防中的阿司匹林：证据或教条？
John G F Cleland
John G F Cleland
Error in Figure [0.03%]
图中错误
Published Erratum
JAMA cardiology. 2024 Dec 4:e244925. DOI:10.1001/jamacardio.2024.4925 2024
Anthony Angueira,Sarah A Abramowitz,Michael G Levin
Anthony Angueira
Long-Term Aspirin vs Clopidogrel After Coronary Stenting by Bleeding Risk and Procedural Complexity [0.03%]
基于出血风险和操作复杂程度的冠脉支架植入术后长期应用阿司匹林与氯吡格雷的研究
Jeehoon Kang,Jaewook Chung,Kyung Woo Park et al.
Jeehoon Kang et al.
Importance: Antiplatelet monotherapy in the chronic maintenance period for patients with high bleeding risk (HBR) and those who have undergone complex percutaneous coronary intervention (PCI) has not yet been explored. ...
Alternative LDL Cholesterol-Lowering Strategy vs High-Intensity Statins in Atherosclerotic Cardiovascular Disease: A Systematic Review and Individual Patient Data Meta-Analysis [0.03%]
非高强度他汀类药物的替代低密度脂胆固醇降低策略在动脉粥样硬化性心血管疾病中的应用：系统评价和个体患者数据meta分析
Yong-Joon Lee,Bum-Kee Hong,Kyeong Ho Yun et al.
Yong-Joon Lee et al.
Importance: In patients with atherosclerotic cardiovascular disease (ASCVD), intensive lowering of low-density lipoprotein (LDL) cholesterol levels with high-intensity statins is generally recommended. However, alternativ...
Goran Medimurec,Željko Ðuric,Irena Ivanac Vranešic
Goran Medimurec
Semaglutide Eligibility Across All Current Indications for US Adults [0.03%]
美国成人在目前所有适应症下的司美格鲁肽适用情况
Ivy Shi,Sadiya S Khan,Robert W Yeh et al.
Ivy Shi et al.
Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction [0.03%]
心力衰竭且射血分数轻度降低或保留患者的钠-葡萄糖共转运体-2抑制剂的早期应用
Mohammad Abdel Jawad,John A Spertus,Uchechukwu Ikeaba et al.
Mohammad Abdel Jawad et al.
Importance: Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are the first therapy shown to improve clinical outcomes for patients with heart failure (HF) and a left ventricular ejection fraction (LVEF) greater than 40...